BUB: Permanent FDA approval secures U.S. market access and unlocks new growth and innovation opportunities
Permanent FDA authorization for three SKUs enables accelerated U.S. growth, validates the supply chain, and supports expansion into premium infant formula segments. The company now holds a strong national presence, is pursuing contract manufacturing, and plans further brand and distribution investm…
Story updates
02:24:11 AM UTC
SquawkNews
Permanent FDA authorization for three SKUs establishes a strong position in the U.S. premium infant formula market, enabling expansion, innovation, and long-term investment. The company is now present in nearly 12,000 stores nationwide and is pursuing contract manufacturing opportunities.Based on B…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.